Animal models for AML, MDS and MPN

被引：0
|
作者：
Kitamura, Toshio [1 ]
机构：
[1] Univ Tokyo, Inst Med Sci, Div Stem Cell Therapy, Div Cellular Therapy, Tokyo 1138654, Japan
来源：
JOURNAL OF GENE MEDICINE | 2014年 / 16卷 / 7-8期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
E-3
引用
收藏
页码：197 / 197
页数：1
相关论文
共 50 条
  • [1] MOLECULAR BASIS FOR AML, MDS AND MPN
    Kitamura, T.
    Nakahara, F.
    Kato, N.
    Watanabe-Okochi, N.
    Komeno, Y.
    Doki, N.
    Togami, K.
    Uchida, T.
    Kagiyama, Y.
    Inoue, D.
    Enomoto, Y.
    Oki, T.
    Harada, H.
    Chiba, S.
    Kitaura, J.
    EXPERIMENTAL HEMATOLOGY, 2010, 38 (09) : S107 - S108
  • [2] ISOLATED MYELOSARCOMA TREATED AS AML, WITH PROGRESSION TO MDS/MPN
    Fuentes, A.
    LaBier, G.
    Boulmay, B.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2018, 66 (02) : 440 - 440
  • [3] High MYC Protein Expression in MDS and MDS/MPN Predicts Early Disease Transformation to AML
    Gajzer, David
    Basra, Pukhraz
    Seongseok, Yun
    Zhang, Ling
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1290 - 1291
  • [4] High MYC Protein Expression in MDS and MDS/MPN Predicts Early Disease Transformation to AML
    Gajzer, David
    Basra, Pukhraz
    Seongseok, Yun
    Zhang, Ling
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1290 - 1291
  • [5] Concurrent Gene Mutations Differ in SF3B1 Mutated MDS, MDS/MPN and AML
    Alexander, Andrew
    Chen, Yi-Hua
    Gao, Juehua
    LABORATORY INVESTIGATION, 2019, 99
  • [6] Concurrent Gene Mutations Differ in SF3B1 Mutated MDS, MDS/MPN and AML
    Alexander, Andrew
    Chen, Yi-Hua
    Gao, Juehua
    MODERN PATHOLOGY, 2019, 32
  • [7] Overlap MDS/MPN
    Cross, N.
    LEUKEMIA RESEARCH, 2013, 37 : S4 - S4
  • [8] Treatment of MDS/MPN and the MDS/MPN IWG International Trial: ABNL MARRO
    Kuykendall, Andrew T.
    Padron, Eric
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2019, 14 (06) : 543 - 549
  • [9] Treatment of MDS/MPN and the MDS/MPN IWG International Trial: ABNL MARRO
    Andrew T. Kuykendall
    Eric Padron
    Current Hematologic Malignancy Reports, 2019, 14 : 543 - 549
  • [10] Comparing Outcomes of Patients with Secondary AML: Treatment-Related MDS/AML, AML Secondary to Myeloproliferative Neoplasms (t-MPN), and AML with Prior Malignancies
    Arana, Cecilia Y.
    Kantarjian, Hagop M.
    Garcia-Manero, Guillermo
    Wierda, William G.
    Borthakur, Gautam
    Quintas-Cardama, Alfonso
    Konopleva, Marina
    Faderl, Stefan
    Pierce, Sherry A.
    Andreeff, Michael
    Ravandi, Farhad
    Cortes, Jorge E.
    BLOOD, 2012, 120 (21)
12345